BOARD OF DIRECTORS
Casey Cunningham, MD
Dr. Cunningham is the Chief Scientific Officer of Santé Ventures, an early-stage life science venture capital firm.
Stephen Howard
Mr. Howard is an initial investor in the technology behind Molecular Templates and a senior equity analyst with a large international bank.
Kevin M. Lalande
Mr. Lalande is a founder and managing director of Santé Ventures, an early-stage life science venture capital firm.
Eric E. Poma
CEO and President, Molecular Templates
Larry Witte, PHD
Dr. Witte is Senior Vice President of Research at ImClone Systems, a biopharmaceutical company developing novel therapeutic products in the field of oncology.
Management Team
Eric E. Poma, PHD
Dr. Poma has been with Molecular Templates as its CEO and President since its inception. He was most recently Vice President, Business Development at Innovive Pharmaceuticals, a clinical stage oncology company that was acquired in 2008. Prior to Innovive, Dr. Poma was Assistant Vice President, Business Development at ImClone Systems. Dr. Poma holds a PHD in Microbiology and Immunology from the University of North Carolina and an MBA in Finance from the Stern School of Business.
Jason Kim
Mr. Kim joined Molecular Templates as CFO in 2010. Previously, Mr. Kim led corporate and business development initiatives at OSI Pharmaceuticals. He has also served as an Associate at Domain Associates and Safeguard Scientifics where he focused on venture and public investments in the biotechnology sector. In addition, Mr. Kim served as Director, Business Development at ImClone Systems. Mr. Kim holds an MBA from The Wharton School and a BA in Neuroscience from Wesleyan University.
Jean Gariepy, PHD
Dr. Gariepy is a founding member of Molecular Templates and its Chief Scientific Officer. He is a world- renowned toxin expert and founder of the technology behind Molecular Templates. Dr. Gariepy is Senior Scientist at the Ontario Cancer Institute. Dr. Gariepy received his PHD from the University of Alberta in Biochemistry.
Leigh Revers, D.Phil.
Dr. Revers is a founding member of Molecular Templates and its Vice President of Research and Development. Dr. Revers is a co-founder of the technology behind Molecular Templates. He is an Associate Director at the MBiotech Program at the University of Toronto and a former recipient of the Leverhulme Scholarship. Dr. Revers received his doctoral degree in Physical Sciences from University of Oxford.